EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights

Gowtam Mannam, Justin W Miller iD, Jeffrey S Johnson, Keerthi Gullapalli, Adnan Fazili, Philippe E Spiess iD, Jad Chahoud

Pathogens · 18.09.2024 · 13 (9) · 809

DOI: 10.3390/pathogens13090809 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 18.09.2024. Verfasst von Gowtam Mannam und 6 weiteren Autor:innen. Beteiligte Einrichtung: USF Health Morsani College of Medicine, Tampa, FL 33602, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Penile Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Penile cancer (PC) is a rare malignancy predominantly of squamous cell origin. Approximately 40% of penile tumors are associated with human papillomavirus (HPV) infection. Diagnosing PC remains challenging due to its rarity and variety of clinical presentations. Furthermore, the impact of HPV on the tumor immune microenvironment complicates clinical management, although recent advancements in immune checkpoint inhibitors (ICIs) have shown some efficacy in treating HPV-associated PC. Ongoing research efforts aim to develop oncologic treatments that target HPV-induced cellular modifications. Additionally, novel therapeutic vaccines and adoptive T-cell therapies targeting HPV oncoproteins represent emerging treatment modalities. Our review highlights the complex interplay between HPV and penile carcinogenesis, emphasizing its epidemiology, etiology, clinicopathological characteristics, and potential therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsPenile NeoplasmsHumansMaleImmune Checkpoint InhibitorsPapillomaviridaeRisk FactorsTumor Microenvironment

Stichwörter der Autor:innen

HPVPSCChuman papillomavirusimmunotherapypenile cancerpenile tumortumor immune microenvironment

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • USF Health Morsani College of Medicine, Tampa, FL 33602, USA.
  • Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

ORCID-Profile: Justin W Miller, Philippe E Spiess

Zitieren

APA

Mannam, G., Miller, J. W., Johnson, J. S., Gullapalli, K., Fazili, A., Spiess, P. E., & Chahoud, J. (2024). HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights. Pathogens, 13(9), 809. https://doi.org/10.3390/pathogens13090809

Vancouver

Mannam G, Miller JW, Johnson JS, Gullapalli K, Fazili A, Spiess PE, et al. HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights. Pathogens. 2024;13(9):809. doi:10.3390/pathogens13090809

BibTeX
@article{Mannam2024,
  author = {Mannam, Gowtam and Miller, Justin W and Johnson, Jeffrey S and Gullapalli, Keerthi and Fazili, Adnan and Spiess, Philippe E and Chahoud, Jad},
  title = {HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights},
  journal = {Pathogens},
  year = {2024},
  volume = {13},
  number = {9},
  pages = {809},
  doi = {10.3390/pathogens13090809}
}
Kostenlos starten →